SCHEMBL6447298

SCHEMBL6447298

CCc1c(Cl)c(Cl)cc2c1nc(CC)n2-c1ccccc1

nearest known ligand 0.49

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
DCTPP1 Q9H773 2/20 0.49
MAT2A P31153 4/20 0.40
CYP1A2 P05177 2/20 0.39
PDE10A Q9Y233 2/20 0.39
P2RX7 Q99572 1/20 0.38
ALDH1A1 P00352 2/20 0.37
MAPK1 P28482 1/20 0.36
HTT P42858 1/20 0.36
SMN1; SMN2 Q16637 2/20 0.35
POLB P06746 1/20 0.35
RECQL P46063 1/20 0.35
HTR2A P28223 2/20 0.35
HTR2C P28335 2/20 0.35
PRMT5 O14744 1/20 0.34
NR1H2 P55055 1/20 0.34
NR1H3 Q13133 1/20 0.34
SLC6A4 P31645 1/20 0.34
KDM4E B2RXH2 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10818689 0.71 CYP1A2 (0.54) MAT2ACYP1A2PDE10AMAPK1HTT
SCHEMBL762447 0.69 MAPK1 (0.66) CYP1A2PDE10AALDH1A1MAPK1HTT
SCHEMBL7814352 0.69 HCAR1 (0.34) DCTPP1MAT2ACYP1A2PDE10AP2RX7
SCHEMBL25112562 0.68 PDE10A (0.63) PDE10AALDH1A1
SCHEMBL10818437 0.68 PDE10A (0.56) CYP1A2PDE10AALDH1A1MAPK1HTT
SCHEMBL1318443 0.68 MAPK8 (0.50) MAT2ACYP1A2ALDH1A1MAPK1HTT
SCHEMBL3441050 0.67 PI4KA (0.49) MAT2AMAPK1POLB
SCHEMBL23912375 0.66 PIK3CD (0.48) MAT2AALDH1A1SMN1; SMN2POLBRECQL
SCHEMBL23105555 0.66 L3MBTL1 (0.45) CYP1A2PDE10AMAPK1SMN1; SMN2NR1H2
SCHEMBL17671374 0.66 DCTPP1 (1.00) DCTPP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1499305-A2 USE OF EP4 RECEPTOR LIGANDS IN THE TREATMENT OF IL-6 INVOLVED DISEASES Pfizer Japan Inc. (JP) 2005-01-26 EP disclosed
WO-2003086371-A2 USE OF EP4 RECEPTOR LIGANDS IN THE TREATMENT OF IL-6 INVOLVED DISEASES PFIZER JAPAN INC. (JP) 2003-10-23 WO disclosed